A comparison of the PANSS Pentagonal and Van Der Gaag 5-factor models for assessing change over time

Psychiatry Research

Volumn 207, Issue 1-2, 2013, Pages 134-139

  Jerrell, Jeanette M ^a   Hrisko, Stephanie ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Positive and negative symptoms; RCT data re analyzed; Repeated measures analysis; Schizophrenia

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CHANGE OVER TIME; CHRONICITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POSITIVE AND NEGATIVE SYNDROME SCALE PENTAGONAL; PRIORITY JOURNAL; PROCESS MODEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL PARAMETERS; VAN DER GAAG 5 FACTOR MODEL;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SINGLE-BLIND METHOD; TIME FACTORS; YOUNG ADULT;

EID: 84876820594     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.12.010     Document Type: Article

References (30)

1. Akaike, H., 1973. Information theory and an extension of the maximum likelihood principle. In: Petrov, B., Csaki, F. (Eds.), Second International Symposium on Information Theory. Akademiai Kiado, Budapest, pp. 267-281.
2. Akaike H. Factor analysis and AIC. Psychometrika 1987, 52:317-332.
3. Blouin A. C-DIS Management Group: Computer-based Diagnostic Interview Schedule Revised 1991, C-DIS Management Group, Toronto.
4. Burnham K.P., Anderson D.R. Multimodel inference: understanding AIC and BIC in model selection. Sociological Methods and Research 2004, 33:261-304.
5. Cuesta M.J., Peralta V. Psychopathological dimensions in schizophrenia. Schizophrenia Bulletin 1995, 21(3):473-482.
6. Davis J.M., Chen N. The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials. Journal of Clinical Psychiatry 2001, 62:757-771.
7. Dollfus S., Everitt B., Ribeyre M., Assouly-Besse F., Sharp C., Petit M. Identifying subtypes of schizophrenia by cluster analysis. Schizophrenia Bulletin 1996, 22(3):545-555.
8. Drake R.J., Pickles A., Bentall R.P., Kinderman P., Haddock G., Tarrier N., Lewis S.W. The evolution of insight, paranoia and depression during early schizophrenia. Psychological Medicine 2004, 34(2):285-292.
9. El Yazaji M.E., Battas O., Agoub M., Moussaoui D., Gutknect C., Dalery J., d'Amato T., Saoud M. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia. Schizophrenia Research 2002, 56:121-127.
10. Emsley R., Rabinowitz J., Torreman M. The factor structure for the Positive and negative syndrome scale (PANSS) in recent-onset psychosis. Schizophrenia Research 2003, 61:47-57.
11. Fitzgerald P.B., de Castella A.R., Brewer K., Filia K., Collins J., Davey P., Rolfe T., Kulkarni J. A confirmatory factor analytic evaluation of the pentagonal PANSS model. Schizophrenia Research 2003, 61:97-104.
12. Hedeker D., Gibbons R.D. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychological Methods 1997, 2:64-78.
13. Janicak P.G., Glick I.D., Marder S.R., Crandall D.T., McQuade R.D., Marcus R.N., Eudicone J.M., Assuncao-Talbott S. The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies. Journal of Clinical Psychiatry 2009, 70(1):25-35.
14. Jerrell J.M. Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications. Schizophrenia Bulletin 2002, 28(4):589-605.
15. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
16. Kay S.R., Sevy S. Pyramidical model of schizophrenia. Schizophrenia Bulletin 1990, 16(3):537-545.
17. Lancon C., Auquier P., Nayt G., Reine G. Stability of the five-factor structure of the positive and negative syndrome scale (PANSS). Schizophrenia Research 2000, 42:231-239.
18. Lehoux C., Gobeil M.H., Lefebvre A.A., Maziade M., Roy M.A. The five-factor structure of the PANSS: a critical review of its consistency across studies. Clinical Schizohrenia & Related Disorders 2009, 3(2):103-110.
19. Levine S.Z., Rabinowitz J. Revisiting the 5 dimensions of the positive and negative syndrome scale. Journal of Clinical Psychopharmacology 2007, 25(5):431-436.
20. Lindenmayer J.P., Grochowski S., Hyman R.B. Five factor model of schizophrenia: replication across samples. Schizophrenia Research 1995, 14:229-234.
21. Lykouras L., Oulis P., Psarros K., Kaskalopoulou E., Botsis A., Christodoulou G.N., Stefanis C. Five-factor model of schizophrenic psychopathology: how valid is it?. European Archives of Psychiatry and Clinical Neuroscience 2000, 250:93-100.
22. Mass R., Schoemig T., Hitschfeld K., Wall E., Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophrenia Bulletin 2000, 26(1):167-177.
23. Nakaya M., Suwa H., Ohmori K. Latent structures underlying schizophrenic symptoms: a five-dimensional model. Schizophrenia Research 1999, 39:39-50.
24. Ngo, L., Brand, R., 2002. Model selection in linear mixed effects models using SAS Proc Mixed. SAS Users Group International. SUGI Paper 22.
25. Van den Oord E.J.C.G., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszar J., Murrelle L., Moller H.J., Middleton L., Muglia P. Factor structure and external validity of the PANSS revisited. Schizophrenia Research 2006, 82:213-223.
26. Van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Wiersma D. The five-factor model of the positive and negative syndrome scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophrenia Research 2006, 85:273-279.
27. Van der Gaag M., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., van Harten P.N., Valmaggia L., de Hert M., Cuijpers A., Wiersma D. The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schizophrenia Research 2006, 85:280-287.
28. White L. Interpreting the PANSS: measures, factors and models. Schizophrenia Research 2005, 79:349-351.
29. White L., Harvey P.D., Opler L., Lindenmayer J.P., the PANSS Study Group Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology 1997, 30:263-274.
30. Wolthaus J.E.D., Dingemans P.M.A.J., Schene A.H., Linszen D.H., Knegtering H., Holthausen E.A., Cahn W., Hijman R. Component structure of the Positive and Negative Syndrome Scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology 2000, 140:399-403.